Eterna Therapeutics closes $1.1M private placement, exchanges debt for equity, addresses Nasdaq compliance

Ernexa Therapeutics Inc.

Stockholders approved issuance of shares for September 2024 transactions at Oct 29 annual meeting.
Closed private placement: issued 1,401,994 shares + 115,000 pre-funded warrants; gross proceeds $1.1M.
Exchange transactions: issued 38,302,029 shares for outstanding warrants and convertible notes.
Bridge notes converted: 6,244,237 shares + 1,764,000 pre-funded warrants; $0.50 conversion price.
Post-closing cap: ~51.4M shares outstanding; Nasdaq hearing on Nov 12 to address equity compliance.

item 1.01 item 8.01 item 3.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-042902
form_type: 8-K
ticker: ERNA
cik: 0000748592
company_name: Ernexa Therapeutics Inc.
filed_at: 2024-10-29T23:59:59+00:00
discovered_at: 2026-05-14T18:03:10.965343+00:00
generated_at: 2026-05-30T09:29:18.477625+00:00
sec_items: ["1.01", "8.01", "3.02", "5.07", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-042902
json_url: https://secwatch.observer/filing/0001493152-24-042902.json
markdown_url: https://secwatch.observer/filing/0001493152-24-042902.md
text_url: https://secwatch.observer/filing/0001493152-24-042902.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/748592/000149315224042902/0001493152-24-042902-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/748592/000149315224042902/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CNL Strategic Capital, LLC

Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks

CNL Strategic Capital, LLC June 2, 2026, 4:04 PM ET other_material Items 1.01, 2.03, 5.07, 8.01, 9.01

same SEC item: 1.01, 5.07, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

QMCO

Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance

QUANTUM CORP /DE/ June 2, 2026, 10:41 AM ET other_material Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01

same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TPST

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Orgenesis Inc.

Orgenesis shareholders approve 10x increase in authorized shares to 150M and convertible loan deal

Orgenesis Inc. June 2, 2026, 5:26 PM ET other_material Items 5.03, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

XMTR

Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M

Xometry, Inc. June 2, 2026, 5:26 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

HYMC

Hycroft TRS shows $10B NPV at spot; 51-year mine life with 10.4M oz gold

HYCROFT MINING HOLDING CORP June 2, 2026, 4:31 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TTI

TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex

TETRA TECHNOLOGIES INC June 2, 2026, 4:26 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-042902

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.